Discusión

Titulo

Comunicación Nº: 031

PAAF en 3 casos de Hiperplasia Angiofolicular Linfoide (Enfermedad de Castleman). Correlación cito-histológica y su obligada referencia con la clínica del paciente.

Ursúa Sarmiento I. , Parra Pérez C., Moro Rodríguez E. y Valle Manteca A.

Servicio de Anatomía Patológica. Hospital Virgen de la Concha. Zamora. España.

--- Dirección para comentarios: jemoro@lander.es---

[Título] [Introducción] [Material y Métodos] [Resultados] [Iconografía] [Discusión]

BIBLIOGRAFÍA

  1. Arranz R., Montesinos C., López-Botet M. et al.: Enfermedad de Castleman: descripción y comentarios a propósito de 3 casos. Med Clin (Barc.), 105(16): 638-9, 1995.
  2. Domínguez F., Riera JR., Junco P. et al.: Linfadenopatía generalizada con hallazgos morfológicos de hiperplasia ganglionar angiofolicular multicéntrica en un paciente con síndrome de inmunodeficiencia adquirida. Rev Clin Esp, 193(6): 299-302, 1993.
  3. Gould SJ., Diss T., Isaacson PG.: Multicentric Castleman s disease in association with a solitary plasmacytoma. A case report. Histopathol, 17: 135-140, 1990.
  4. Henry K.: Lymph nodes. In:Thymus, Lymph Nodes, Spleen and Lymphatics. Henry and Symmers Eds.Churchill Livingstone, London, pp: 207-218, 1992.
  5. Isaacson PG.: Commentary: Castleman s disease. Histopathol, 14: 429-432, 1989.
  6. Ishiyama T., Koike M., Fukuchi K. et al.: Apoptosis of T cells in multicentric Castleman s disease. Clin Immunol Immunopathol, 79(3): 271-7, 1996.
  7. Koss L., Woyke S. y Olszewski W.: Ganglios linfáticos. En: Biopsia por aspiración. Panamericana. Buenos Aires, pág.:137-184, 1988.
  8. Lajoie G., Kumar S., Min KW. et al.: Renal thrombotic microangiopathy associated with multicentric Castleman s disease. Report two cases. Am J Surg Pathol, 19(9): 1021-8, 1995.
  9. Leger-Ravet M., Peuchmaur M., Devergne O. et al.: Interleukin 6 gene expression in Castleman s disease. Blood, 78: 2923-30, 1991.
  10. Mandler RN., Kerrigan DP., Smart J. et al.: Castleman s disease in POEMS syndrome with elevated interleukin 6. Cancer, 69: 2697-2703, 1992.
  11. McCarty MJ., Vukelja SJ., Banks PM. et al.: Angiofollicular lymph node hyperplasia (Castleman s disease). Cancer Treat Rev, 21(4): 291-310, 1995.
  12. Menke DM., Tiemann M., Camoriano JK. et al.: Diagnosis of Castleman s disease by identification of a immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embebed lymph biopsies. Am J Clin Pathol, 105(3): 268-76, 1996.
  13. Nguyen DT., Diamond LW. Hansmann ML. et al: Differences in follicular dendritic network in the hialine vascular and plasma cell variants. Histopathol, 24: 437-43, 1994.
  14. Ohyashiki JH., Ohyashiki K., kawakubo K et al.: Molecular genetic, cytogenetic and immunophenotypic analyses in Castleman s disease of plasma cell type. Am J Clin Pathol, 101(3): 290-4, 1994.
  15. Ordi J., Grau JM., Junque A. et al.: Secondary amyloidosis associated with Castleman s disease. Report of two cases and review of the literature. Am J Clin Pathol, 100: 394-97, 1993.
  16. Ruco LP., Gearing AJ., Pigott R. et al.: Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia. Evidence for dysplasia of follicular dendritic reticulum cells. Histopathol, 19: 523-28, 1989.
  17. Soulier J., Grollet L., Oksenhndler E. et al.: Molecular analysis of clonality in Castleman s disease. Blood, 86(3): 1131-8,1995.
  18. Vasef M., Katzin WE., Mendelshon G. et al: Report of a case of localized Castleman s disease with progression to malignant lymphoma. Am J Clin Pathol, 98: 633-6, 1992.
  19. Winter SS., Howard TA., Ritchey AK. et al: Elevated levels of tumor necrosis factor-beta, gamma-interferon and IL-6 mRNA in Castlemal s disease. Med Pediatr Oncol, 26(1): 48-53, 1996.
  20. Zárate-Osorno A., Medeiros LJ., Danon AD. et al: Hodgkin s disease with coexisten Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med, 118: 270-4, 1994.

Discusión

Titulo